Biophotonics Market Thumbnail Image

2022

Biophotonics Market

Biophotonics Market By End User (Medical Diagnostics, Medical Therapeutic, Tests & Components, and Nonmedical Application) and Application (See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy, Analytical Sensing, and Biosensors): Global Opportunity Analysis and Industry Forecast, 2021-2030

Select an option
Author's: Avinash Savekar | Vineet Kumar
Publish Date:

Get Sample to Email

Biophotonics Market Outlook – 2030

The global biophotonics market size was valued at $52.17 billion in 2020, and is projected to reach $133.90 billion by 2030, growing at a CAGR of 10.50% from 2021 to 2030.

The science of generating and utilizing light to visualize, detect, and modify biological components is known as biophotonics.. It uses light and other forms of radiant energy to understand the internal functioning of cells and tissues in living organisms. Biophotonics is used in biology to study molecular processes, functions, and structures. In medicine, it is used to study light–tissue interactions at the micro, nano, and macro-organism level to detect, diagnose, and treat diseases. Moreover, it helps in emission, detection, absorption, reflection, modification, and generation of radiation from bimolecular, cells, tissues, organisms, and biomaterials.

Biophotonics-Market.jpg

Biosensors are analytical devices that can detect chemical or biological species or a microorganism. They can be used to monitor the changes in the in vivo concentrations of species as a function of a physiological change induced internally or by invasion of a microbe, and also as a biophotonic scanner. A biosensor in general utilizes a biological recognition element that senses the presence of an analyte (the species to be detected) and creates a physical or chemical response that is converted by a transducer to a signal. There are several types of biosensors, but the optical sensor is one that is utilized in biophotonics for disease diagnosis and prevention.

Biophotonics Market
By End User
Your browser does not support the canvas element.

Nonmedical Application segment will grow at a highest CAGR of 13.4% during 2021 - 2030.

Biophotonics technology is expected to witness notable growth in the coming years owing to development in biosensors and its increased use in the nonmedical sector. Availability of funds for R&D is expected to fuel the growth of the market during the forecast period. The impact of these drivers is expected to increase significantly due to rise in awareness about the benefits of the biophotonics. However, high price of biophotonics-based instruments due to complexity of technology restrains the growth of the market. Nevertheless, with the advancement in the technology, cost of biophotonics devices is expected to reduce in the coming years. 

Practice of nanotechnology in healthcare sector helps a lot in sensing human cells and tissues. For example, for a cancer patient usage of biophotonics helps in connecting with the directly affected cells and improves the process of curing. Increase in penetration of advanced healthcare devices fuel the growth in biophotonics market.

Segment Review

The biophotonics market is segmented on the basis of end user, application, and region. On the basis of end user, the market is segmented into medical diagnostics, medical therapeutic, tests & components, and non-medical application. On the basis of application, it is segmented into see-through imaging, inside imaging, spectro molecular, surface imaging, microscopy, light therapy, analytical sensing, and biosensors.  

Biophotonics Market
By Application
Your browser does not support the canvas element.

Analytics Sensing segment generated the highest revenue in 2020.

On the basis of region, the biophotonics market trends are analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa). North America is the most dominant market for biophotonics due to the growing initiative from the government and medical industry. The overall biophotonics market analysis is determined to understand the profitable trends to gain a stronger foothold.  

Competitive Analysis 

The key players profiled in the report include Thermo Fisher Scientific Inc., Oxford Technologies, Carl Zeiss AG, Becton Dickinson and Company, Glenbrook Technologies Inc., Hamamatsu Photonics K.K., Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., and Zenalux Biomedical Inc. These players have adopted various strategies, such as product development, and product launch, and acquisition to expand their foothold in biophotonics industry.

Top Impacting Factors

The prominent factors that impact the biophotonics market growth are the emergence of nanotechnology, R&D in the field of optics, increased use of biophotonic devices for medical & nonmedical purposes. However, high equipment cost restricts the market growth. On the contrary, use of biophotonics in non-medical sectors is expected to create lucrative opportunities for the market. Therefore, these factors are expected to definitely affect global industry during the forecast period.    

Covid-19 Impact Analysis

COVID-19 have a huge impact on both consumer as well as the economy. The states of emergency declared around the globe, the photonics market is starting to feel the impacts of the virus and global supply chains are beginning to slow, and prominent trade shows are beginning to realize widespread cancellations and dropouts amid concern about the viral disease. 

The lack of business continuity has ensured significant negative impacts on revenue and shareholder returns, which are expected to create financial disruptions in the biophotonics industry. 

Moreover, the outbreak of corona virus constrained governments across the globe to force lockdown initiatives that reduced the sales and production revenue, which in turn disrupted the worldwide economy at a significant extent. Therefore, the biophotonics market size is anticipated to gain momentum by the end of 2022. 

Biophotonics Market
By Region
2030
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific would exhibit the highest CAGR of 11.8% during 2020-2030

Key Benefits For Stakeholders

  • This study comprises analytical depiction of the global biophotonics market outlook along with the current trends and future estimations to depict the imminent investment pockets. 
  • The overall biophotonics market analysis is determined to understand the profitable trends to gain a stronger foothold.  
  • The report presents information related to key drivers, restraints, and biophotonics market opportunities with a detailed impact analysis.   
  • The current biophotonics market forecast is quantitatively analyzed from 2020 to 2030 to benchmark the financial competency.    
  • Porter’s five forces analysis illustrates the potency of the buyers and the biophotonics market share of key vendors.    
  • The report includes the market trends and the revenue share of key vendors. 

Biophotonics Market Report Highlights

Aspects Details
Biophotonics Market By End User
By End User
  • Medical Diagnostics
  • Medical Therapeutic
  • Tests & Components
  • Nonmedical Application
Biophotonics Market By Application
By Application
  • See-through Imaging
  • Inside Imaging
  • Spectro Molecular
  • Surface Imaging
  • Microscopy
  • Light Therapy
  • Analytical Sensing
  • Biosensors
Biophotonics Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (UK, Germany, France, Italy, Rest of Europe)
  • Asia-Pacific  (China, India, Japan, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Latin America, Middle East, Africa)
Biophotonics Market By KEY PLAYERS
By KEY PLAYERS
  • Thermo Fisher Scientific Inc.
  • Oxford Technologies
  • Carl Zeiss AG
  • Glenbrook Technologies Inc.
  • Becton, Dickinson and Company
  • Hamamatsu Photonics K.K.
  • Lumenis Ltd.
  • Olympus Corporation
  • PerkinElmer Inc.
  • Zenalux Biomedical Inc.

Analyst Review

According to CXO perspective, the emergence of nanotechnology, development in biosensors, and availability of funds for R&D, and increase in use of biophotonic devices in nonmedical application drives biophotonic market growth. However, the high cost of biophotonics-based instruments due to complexity of technology is hampering its adoption. Furthermore, advancement in the technology is  anticipated to provide lucrative opportunity for the biophotonics market during the forecast period. 

Analytical sensing and biosensors are projected to show high growth rate during the forecast period, owing to the need for better methods for environmental monitoring and rapid pathogen detection. The biosensors industry is expanding to encompass nonclinical applications such as defense, environmental surveillance, and food manufacturing units.

North America accounted for the highest revenue in 2021, due to increase in the use of biophotonic devices for medical and non-medical applications. This has resulted in technological advancement and launch of new products by the key players of the market. Asia-Pacific is expected to maintain its dominant position over the forecast period.

The report focuses on the growth prospects, restraints, and trends of the biophotonics market analysis. The study provides Porter’s five forces analysis to understand the impact of various factors, such as bargaining power of suppliers, competitive intensity of competitors, threat of new entrants, threat of substitutes, and bargaining power of buyers, in the biophotonics market.  

Author Name(s) : Avinash Savekar | Vineet Kumar
Frequently Asked Questions?

The Biophotonics Market is estimated to grow at a CAGR of 10.50% from 2021 to 2030.

The Biophotonics Market is projected to reach $133.90 billion by 2030.

To get the latest version of sample report

Factors such as Thermo Fisher Scientific Inc., Oxford Technologies, Carl Zeiss AG, Becton Dickinson and Company, Glenbrook Technologies Inc., Hamamatsu Photonics K.K., Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., and Zenalux Biomedical Inc drives the growth of the Biophotonics market

The key players profiled in the report include American Security Products Co., Access Security Products Ltd., Alpha Safe & Vault, Inc., Acme Security Systems, BJARSTAL, Bode-Panzer GmbH, Diebold Nixdorf Incorporated, Dormakaba, Gunnebo Industries AB, and Godrej & Boyce Manufacturing Co. Limited, and many more.

On the basis of top growing big corporations, we select top 10 players.

The Biophotonics Market is segmented on the basis of end user, application, and region.

The key growth strategies of Biophotonics market players include product portfolio expansion, mergers & acquisitions, agreements, geographical expansion, and collaborations.

Subsegments of application are see-through imaging, inside imaging, spectro molecular, surface imaging, microscopy, light therapy, analytical sensing, and biosensors.

Nonmedical Application segment will grow at a highest CAGR of 13.4% during 2021 - 2030.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Biophotonics Market

Global Opportunity Analysis and Industry Forecast, 2021-2030